... Read more »

ME Newswire / Business Wire

INGELHEIM, Germany - Tuesday, March 5th 2013

    80 percent of patients achieved early treatment success* with faldaprevir^ plus PegIFN/RBV highlighting the potential to reduce treatment duration from 48 to 24 weeks
    Interim results indicate potent activity of faldaprevir in HCV/HIV co-infected patients

For media outside of the U.S.A., UK and Canada only

Interim study results from STARTversoTM 4 presented today at CROI+ show that 80 percent of hepatitis C (HCV) patients also infected with HIV achieved early treatment success with faldaprevir (BI 201335) combined with pegylated interferon and ribavirin (PegIFN/RBV).1 These patients have a high unmet medical need due to limited treatment options; up to 10 million people2 are co-infected with HIV and HCV worldwide and it is estimated that only around one-third of those diagnosed actually receive HCV treatment.3

These interim results from ST ... Read more »

DALLAS - Tuesday, March 5th 2013 [ME NewsWire]

(BUSINESS WIRE)-- Xtera Communications, Inc. ("Xtera”), a leading global provider of optical networking solutions, today announced the launch of OTN switching capabilities on its advanced 100G optical networking platform, Nu-Wave OptimaTM. Xtera now offers a stand-alone or integrated switching solution capable of providing the flexibility and scale necessary to enable service providers to efficiently respond to the continued growth of the Internet, greater prevalence of video content, and more dependence on network-based storage. The benefits of Xtera’s converged Layer 0 WDM transport and Layer 1 OTN switching solution include scalable transport and switching capacity, efficient capacity utilization in backbone networks, high manageability on per service and per wavelength basis, fast service provisioning, quick failure protection, and policy-based restoration.

Using the latest technologies and chipsets, Xtera’s OTN switch in ... Read more »

- Wearable Prototype Senses Electric Cardio Gram, Pulse, Body Temperature and Movement -

TOKYO - Tuesday, March 5th 2013 [ME NewsWire]

ISMICT2013

(BUSINESS WIRE)-- Toshiba Corporation (TOKYO:6502) today announced that it has developed an intelligent vital signs sensor module, Smart healthcare Intelligent Monitor Engine & Ecosystem; Silmee, that simultaneously senses information on key vital signs: Electric Cardio Gram, pulse, body temperature and movements, and that can deliver the data to smartphones and tablet PCs with wireless technology. Toshiba has fabricated a prototype of the sensor module that is small enough to wear, and will present and demonstrate it at the International Symposium on Medical ICT 2013, to be held at Meiji University, Tokyo, Japan on March 7.

Current healthcare cloud and services make use of already developed individual healthcare devices, such as sphygmomanometers or clinical thermometers. Such services face major challenges in ... Read more »